[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335421-105":59,"doc-detail-335421-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-nanomedicine-approaches-in-targeted-lung-cancer-treatment","Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment","","Lung cancer is a leading cause of cancer-related mortality worldwide and is marked by aggressive behavior and unfavorable prognosis. Because conventional chemotherapy lacks specificity, nanomedicine provides targeted therapeutic strategies using nanoparticles engineered to deliver agents directly to cancer cells, reducing systemic toxicity while improving treatment performance. VEGF and VEGFR signaling is implicated in tumor growth, angiogenesis, and metastasis; inhibiting this pathway can disrupt angiogenesis and proliferation. The review surveys recent nanoparticle design advances, including lipid-based, polymeric, and inorganic systems, and links them to diagnostic and treatment implications in lung cancer care.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-nanomedicine-approaches-in-targeted-lung-cancer-treatment/335421/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-nanomedicine-approaches-in-targeted-lung-cancer-treatment/335421.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is nanomedicine considered a promising approach for targeted lung cancer therapy?","Question",{"text":112,"@type":113},"Nanomedicine enables nanoparticles to deliver therapeutic agents directly to cancer cells, minimizing systemic toxicity compared with nonspecific traditional chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do VEGF and VEGFR contribute to lung cancer progression?",{"text":117,"@type":113},"VEGF and VEGFR activate signaling cascades that support tumor development, angiogenesis, and metastasis. Inhibiting these pathways can reduce angiogenesis and proliferation.",{"name":119,"@type":110,"acceptedAnswer":120},"What types of nanoparticles are discussed in the review?",{"text":121,"@type":113},"The review highlights lipid-based, polymeric, and inorganic nanoparticles and their clinical implications for improving lung cancer outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335421,1790018210,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \nEmerging Nanomedicine Approaches in Targeted Lung Cancer Treatment  \nIsaic Alexandru 1, Lavinia Davidescu 2, *, Alexandru Cătălin Motofelea 3, Tudor Ciocarlie 4, Nadica Motofelea 5, Dan Costachescu 6, Monica Steluta Marc 7, Noemi Suppini 7, Alina Simona S, ovrea 8,  \nRăzvan-Lucian Cos, eriu 9, Daniela-Andreea Bondor 10, Laura-Gabriela Bobeică 10 and Andreea Crintea 10  \nCitation: Alexandru, I.; Davidescu, L.; Motofelea, A.C.; Ciocarlie, T.; Motofelea, N.; Costachescu, D.; Marc, M.S.; Suppini, N.; S, ovrea, A.S.;  \nCos, eriu, R.-L.; et al. Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment. Int.  \nJ. Mol. Sci. 2024, 25, 11235. [https://](https://)[ ](https://)[doi.org/10.3390/ijms252011235](doi.org/10.3390/ijms252011235)  \nAcademic Editor: Judit E. Pongracz  \nReceived: 30 July 2024  \nRevised: 15 October 2024  \nAccepted: 17 October 2024  \nPublished: 19 October 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department X of General Surgery,“Victor Babes” University of Medicine and Pharmacy,  \n300041 Timisoara, Romania; [isaic.alexandru@umft.ro](isaic.alexandru@umft.ro)  \n2 Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea,  \n410073 Oradea, Romania  \n3 Department of Internal Medicine, Faculty of Medicine,“Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; [alexandru.motofelea@umft.ro](alexandru.motofelea@umft.ro)  \n4 Department VII Internal Medicine II, Discipline of Cardiology,“Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; [ciocarlie.tudor@umft.ro](ciocarlie.tudor@umft.ro)  \n5 Department of Obstetrics and Gynecology,“Victor Babes” University of Medicine and Pharmacy, Eftimie Murgu Sq. No. 2, 300041 Timisoara, Romania; [nadica.motofelea@umft.ro](nadica.motofelea@umft.ro)  \n6 Radiology Department,“Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; [costachescu.dan@umft.ro](costachescu.dan@umft.ro)  \n7 Discipline of Pulmonology,“Victor Babes” University of Medicine and Pharmacy Timisoara,  \n300041 Timisoara, Romania; [marc.monica@umft.ro](marc.monica@umft.ro) (M.S.M.); [noemi.suppini@umft.ro](noemi.suppini@umft.ro) (N.S.)  \n8 Department of Morphological Sciences,“Iuliu Haieganu” University of Medicine and Pharmacy,  \n400349 Cluj-Napoca, Romania; [simona.sovrea@umfcluj.ro](simona.sovrea@umfcluj.ro)  \n9 Department of Microbiology, University of Medicine, Pharmacy, Science and Technology “George Emil Palade”, 540142 Târgu-Mures, Romania; [lucian-razvan.coseriu@umfst.ro](lucian-razvan.coseriu@umfst.ro)  \n10 Department of Medical Biochemistry,“Iuliu Haieganu” University of Medicine and Pharmacy,  \n400012 Cluj-Napoca, Romania; [bondor.daniela.andre@elearn.umfcluj.ro](bondor.daniela.andre@elearn.umfcluj.ro) (D.-A.B.); [bobeica.laura.gabr@elearn.umfcluj.ro](bobeica.laura.gabr@elearn.umfcluj.ro) (L.-G.B.); [crintea.andreea@elearn.umfcluj.ro](crintea.andreea@elearn.umfcluj.ro) (A.C.)  \n* Correspondence: [lavinia.davidescu@didactic.uoradea.ro](lavinia.davidescu@didactic.uoradea.ro)  \nAbstract: Lung cancer, the leading cause of cancer-related deaths worldwide, is characterized by its aggressive nature and poor prognosis. As traditional chemotherapy has the disadvantage of nonspecificity, nanomedicine offers innovative approaches for targeted therapy, particularly through the development of nanoparticles that can deliver therapeutic agents directly to cancer cells, minimizing systemic toxicity and enhancing treatment efficacy. VEGF and VEGFR are shown tobe responsible for activating different signaling cascades, which will ultimately enhance tumor development, angiogenesis, and meta","cbCaihw735F4NuOx","https://ap.wps.com/l/cbCaihw735F4NuOx","pdf",1928491,"English","# Introduction\n## Epidemiology and burden of lung cancer\n## Etiological factors and disease forms","[{\"question\":\"Why is nanomedicine considered a promising approach for targeted lung cancer therapy?\",\"answer\":\"Nanomedicine enables nanoparticles to deliver therapeutic agents directly to cancer cells, minimizing systemic toxicity compared with nonspecific traditional chemotherapy.\"},{\"question\":\"How do VEGF and VEGFR contribute to lung cancer progression?\",\"answer\":\"VEGF and VEGFR activate signaling cascades that support tumor development, angiogenesis, and metastasis. Inhibiting these pathways can reduce angiogenesis and proliferation.\"},{\"question\":\"What types of nanoparticles are discussed in the review?\",\"answer\":\"The review highlights lipid-based, polymeric, and inorganic nanoparticles and their clinical implications for improving lung cancer outcomes.\"}]","Emerging Nanomedicine Approaches in Targeted Lung Cancer Treatment | PDF",1790010940,48]